Assessment of Biochemical Determinants in Multiple Sclerosis Patients Following the Oral Administration of β-D-Mannuronic Acid (M2000)

Title:Assessment of Biochemical Determinants in Multiple Sclerosis Patients Following the Oral Administration of β-D-Mannuronic Acid (M2000)

Volume: 18 Issue: 5

Author(s): Mohamad Reza Nikouei Moghaddam, Monireh Movahedi, Maryam Bananej, Soheil Najafi, Nahid Beladi Moghadam, Payam Saadat, Fariba Mokhtarian and Abbas Mirshafiey*

Affiliation:

• Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran,Iran

Keywords: Mannuronic acid, M2000, multiple sclerosis, drug safety, toxicology, biochemical markers, NSAIDs.

Abstract: Background: Multiple sclerosis is an autoimmune chronic inflammatory disease of the central nervous system that can lead to some serious disabilities. Despite using various immunomodulatory and anti-inflammatory drugs that have therapeutic effects, they cannot reduce its progression completely and have some unwanted side effects too. The immunomodulatory and anti-inflammatory effects of the β-D-Mannuronic acid (M2000) have been proven in several surveys, and the present research was designed to determine its toxicity and therapeutic effects in MS patients.

Methods: This study was performed on 15 MS patients who took 25 mg/kg/day the oral form of the β-D-Mannuronic acid for six months, and 15 healthy people as a control group. Serum levels of Urea, Creatinine, GGT, Vitamin D3, Uric acid, and Anti-Phospholipids were compared to evaluate the therapeutic and possible toxic effects of this drug after this period.

Results: Non- toxic effects through the study of urea, creatinine, GGT, and non-significant changes in uric acid and anti-Phospholipids levels, besides a significant rise in vitamin, D3 levels in the M2000 treated cases were found.

Conclusions: Our results suggested that β-D-Mannuronic acid is a safe drug and has no toxicity when administered orally and also has some therapeutic effects in MS patients.

Cite this article as:

Nikouei Moghaddam Mohamad Reza , Movahedi Monireh , Bananej Maryam, Najafi Soheil, Moghadam Beladi Nahid , Saadat Payam , Mokhtarian Fariba and Mirshafiey Abbas *, Assessment of Biochemical Determinants in Multiple Sclerosis Patients Following the Oral Administration of β-D-Mannuronic Acid (M2000), Current Drug Discovery Technologies 2021; 18 (5) : e17092020186049 . https://dx.doi.org/10.2174/1570163817999200918104333

DOI https://dx.doi.org/10.2174/1570163817999200918104333	Print ISSN 1570-1638
Publisher Name Bentham Science Publisher	Online ISSN 1875-6220